Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,961.00
+50.10 (2.62%)
Jul 31, 2026, 3:29 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 371.61 billion as of July 31, 2026. Its market cap has increased by 37.35% in one year.
Market Cap
371.61B
Enterprise Value
385.62B
Revenue
92.04B
Ranking
n/a
PE Ratio
40.19
Stock Price
1,961.00
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 371.61B, an increase of 44.63%. That is a compound annual growth rate of 19.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 371.61B | 43.66% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 678.15B |
| Glenmark Pharmaceuticals | 638.25B |
| Ipca Laboratories | 450.20B |
| Ajanta Pharma | 424.18B |
| Gland Pharma | 419.09B |
| Wockhardt | 311.42B |
| Piramal Pharma | 259.70B |
| Eris Lifesciences | 197.67B |